TERT and thyroid gland carcinoma: In thyroid FNAB analyses by Liu et al. [138], 80% of the TERT promoter mutation-positive thyroid cancers exhibited aggressive clinic-pathological behaviors, including extrathyroidal invasion, lymph node metastases, distant metastases, and disease recurrence.